Arcutis Biotherapeutics, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Arcutis Biotherapeutics, Inc. reported Cash And Cash Equivalents At Carrying Value of $53.64 million for the year ending 2022.

  • Arcutis Biotherapeutics, Inc. showed a decrease of -44.4% in Cash And Cash Equivalents At Carrying Value from 2021 to 2022.
  • This data is from Arcutis Biotherapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on February 28, 2023.
  • XBRL data for this metric is available from 2019 to 2022 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 4 years of available data (2019 to 2022), Arcutis Biotherapeutics, Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 15.3%.
  • Historical annual values: Fiscal year 2022: $53.64 million | Fiscal year 2021: $96.45 million | Fiscal year 2020: $65.08 million | Fiscal year 2019: $63.34 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: